Compare Ecolab Inc. (ECL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Ecolab Inc. trades at $273.17 (market cap $76.06B), while Health Care Select Sector SPDR Fund trades at $161.78. The key difference: Ecolab Inc. pays a 1.08% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Ecolab Inc. nearer its low. Which is the better fit depends on your goals.
| ECL | XLV | |
|---|---|---|
Market Cap | $76.06B | — |
Sector | Consumer Cyclical | — |
52-Week High | $308.35 | $164.48 |
52-Week Low | $245.73 | $129.01 |
Enterprise Value | $84.81B | — |
Dividend Yield | 1.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ECL trades at $273.62, up 1.43% with a bearish technical signal despite strong analyst support. The company shows solid fundamentals with $16.08B revenue, 12.8% net margin, and 22.31% ROE. Recent Q1 2026 earnings met expectations while Q2 2026 results are pending. The $4.75B CoolIT acquisition strengthens AI cooling capabilities, positioning for long-term growth in high-tech markets.
ECL presents a compelling growth story with improving profitability and strategic acquisitions, though current valuation multiples appear elevated. Key risks include execution of recent acquisitions and rising cost pressures. With 76% analyst buy ratings and a $327.43 consensus target suggesting 20% upside, the stock offers potential for patient investors despite near-term technical weakness.
XLV trades at $161.47, up 2.01% with a bullish technical signal from moving averages. The healthcare ETF benefits from State Street's upgraded sector outlook and strong performance from holdings like Johnson & Johnson. Technical indicators show support at $156-158 with resistance at $159-161, while RSI readings suggest neutral momentum.
The outlook remains positive as healthcare gains favor for defensive qualities amid market volatility. Key risks include patent expirations and regulatory pressures, but diversified exposure and innovation in biotech/pharma support long-term growth potential. Analyst sentiment favors healthcare for stability and innovation-driven returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
